Naason Science
Preclinical Services That Drive Drug Discovery Forward
23/04/2026
We’re heading to Seoul! 🇰🇷
Naason Science will be exhibiting at BIO KOREA 2026, April 28–30 at COEX Convention & Exhibition Center.
📍 Booth K1
Come meet our team and learn more about our preclinical research models and services.
11/04/2026
Today, on World Parkinson’s Day, we raise awareness of Parkinson´s Disease— a progressive neurodegenerative disorder affecting millions worldwide.
At Naason Science, we support the development of next-generation therapies through robust and translational preclinical models for Parkinson’s disease.
Our capabilities include:
- Validated in vivo models reflecting key disease pathology
- Behavioral assessments for motor and non-motor symptoms
- Histological and biomarker analysis to support translational insights
By combining scientific rigor with efficient study ex*****on, we aim to help our partners move promising therapies closer to patients.
📩 Let’s advance Parkinson’s research together.
13/03/2026
Our latest newsletter is now available!
In this issue:
🔬 A scientist spotlight featuring Yeon-Gyeong Kim
🏢 Updates on our upcoming move to a new laboratory facility
🧬 Our participation in the Women’s Health & Gynecology Congress
Read more here:
https://email.marketing.godaddy.com/view/wkfEJcn735wyZGLHc27CYAg6
08/03/2026
Happy International Women’s Day! 🌸
Today we celebrate women everywhere — in science, healthcare, business, and everyday life.
At Naason Science, we value collaboration, respect, and equal opportunities as part of building strong teams and meaningful research.
Wishing a wonderful International Women’s Day to all women — colleagues, partners, and friends.
30/01/2026
Advanced preclinical models are now available to drive your research forward. Experience the benefits of our innovative platforms designed to enhance drug discovery and development processes.